KRAJCIOVA, Jana, Martin JANICKO, Premysl FALT, Jan GREGAR, Stepan SUCHANEK, Ondřej NGO, Marek KOLLAR, Ondrej URBAN, Vlastimil PROCHAZKA, Miroslav ZAVORAL, Julius SPICAK a Jan MARTINEK. Radiofrequency Ablation in Patients with Barrett's Esophagus-related Neoplasia - Long-Term Outcomes in the Czech National Database. Journal of Gastrointestinal and Liver Diseases. CLUJ-NAPOCA: MEDICAL UNIV PRESS, 2019, roč. 28, č. 2, s. 149-155. ISSN 1841-8724. Dostupné z: https://dx.doi.org/10.15403/jgld-174.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Radiofrequency Ablation in Patients with Barrett's Esophagus-related Neoplasia - Long-Term Outcomes in the Czech National Database
Autoři KRAJCIOVA, Jana (203 Česká republika), Martin JANICKO (703 Slovensko, garant), Premysl FALT (203 Česká republika), Jan GREGAR (203 Česká republika), Stepan SUCHANEK, Ondřej NGO (203 Česká republika, domácí), Marek KOLLAR (203 Česká republika), Ondrej URBAN (203 Česká republika), Vlastimil PROCHAZKA (203 Česká republika), Miroslav ZAVORAL (203 Česká republika), Julius SPICAK (203 Česká republika) a Jan MARTINEK (203 Česká republika).
Vydání Journal of Gastrointestinal and Liver Diseases, CLUJ-NAPOCA, MEDICAL UNIV PRESS, 2019, 1841-8724.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30219 Gastroenterology and hepatology
Stát vydavatele Rumunsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.351
Kód RIV RIV/00216224:14110/19:00112951
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.15403/jgld-174
UT WoS 000475570900006
Klíčová slova anglicky Barrett's esophagus related neoplasia; radiofrequency ablation; neo-Z-line; intestinal metaplasia
Štítky 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 17. 2. 2020 07:42.
Anotace
Background & Aims: Radiofrequency ablation (RFA) with/without endoscopic resection (ER) is the standard endoscopic treatment modality for Barrett's esophagus (BE) related neoplasia (BORN). The main aim of this study was to assess the long-term outcomes of RFA in patients with BORN. Methods: We retrospectively analyzed the prospectively collected data from the Czech national database. Main outcomes were: complete remission of neoplasia (CR-N), complete remission of intestinal metaplasia (CR-IM), recurrence of both neoplasia and IM, and safety. Results: From a total of 170 patients with BORN treated with RFA, 136 patients were analyzed. They were followed up for a median of 27.5 months. Fifty-six patients (41%) had low-grade intraepithelial neoplasia (LGIN), 46 (34%) had high-grade intraepithelial neoplasia (HGIN) and 34 (25%) had early adenocarcinoma (EAC). RFA was combined with previous ER in 65 patients (48%). CR-IM and CR-N were achieved in 77.9% (95% CI 70.0-84.6%) and 98.5% (95% CI 94.8-99.8%). Among 30 patients without CR-IM, 22 (73%) did not have macroscopic signs of BE. Recurrent neoplasia was detected in 4.5% of patients (6/134) and 15% (16/106) experienced a recurrence of IM at the level of the neo-Z-line. Diagnosis of cancer was an independent risk factor for recurrent IM after RFA (OR 7.0, 95% CI 1.6-30.9, p<0.0005). Conclusion: RFA is highly effective in achieving remission in patients with BORN. A significant proportion of patients did not achieve CR-IM or had a recurrence of IM despite macroscopically absent BE. Recurrence of neoplasia was infrequent but not negligible, thus, patients after successful RFA still require endoscopic surveillance.
VytisknoutZobrazeno: 28. 7. 2024 12:16